Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”
Open Access
- 1 May 2014
- journal article
- review article
- Published by Elsevier in American Journal of Transplantation
- Vol. 14 (5), 994-1002
- https://doi.org/10.1111/ajt.12714
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- 1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERSJournal of Hepatology, 2012
- 1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTSJournal of Hepatology, 2011
- Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionHepatology, 2010
- Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver diseaseHepatology, 2010
- Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantationLiver Transplantation, 2009
- Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and RibavirinAmerican Journal of Transplantation, 2006
- Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantationJournal of Hepatology, 2005
- Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus[ndash ]reinfected liverLiver Transplantation, 2002
- Recurrent and New Hepatitis C Virus Infection After Liver TransplantationHepatology, 1999